Compare AMAR REMEDIES with Hindustan Unilever - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

AMAR REMEDIES vs HUL - Comparison Results

HUL 
   Change

HUL, the largest FMCG company in the country constitutes 13% of the industry valued at Rs. 1.6 trillion (AC Nielsen). It is present in over 20 distinct categories in Home & Personal Care Products and Foods & Beverages. Revenue share of the various pr... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    AMAR REMEDIES HUL AMAR REMEDIES/
HUL
 
P/E (TTM) x -0.5 64.9 - View Chart
P/BV x 0.1 55.5 0.1% View Chart
Dividend Yield % 0.0 1.1 -  

Financials

 AMAR REMEDIES   HUL
EQUITY SHARE DATA
    AMAR REMEDIES
Jun-12
HUL
Mar-19
AMAR REMEDIES/
HUL
5-Yr Chart
Click to enlarge
High Rs1641,871 8.8%   
Low Rs861,322 6.5%   
Sales per share (Unadj.) Rs261.6181.6 144.1%  
Earnings per share (Unadj.) Rs17.428.0 62.1%  
Cash flow per share (Unadj.) Rs22.330.6 72.8%  
Dividends per share (Unadj.) Rs022.00 0.0%  
Dividend yield (eoy) %01.4 0.0%  
Book value per share (Unadj.) Rs100.736.3 277.1%  
Shares outstanding (eoy) m26.162,164.53 1.2%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x0.58.8 5.4%   
Avg P/E ratio x7.257.0 12.6%  
P/CF ratio (eoy) x5.652.1 10.8%  
Price / Book Value ratio x1.243.9 2.8%  
Dividend payout %078.6 0.0%   
Avg Mkt Cap Rs m3,2703,454,698 0.1%   
No. of employees `000NA5.6 0.0%   
Total wages/salary Rs m16318,750 0.9%   
Avg. sales/employee Rs ThNM69,636.8-  
Avg. wages/employee Rs ThNM3,321.5-  
Avg. net profit/employee Rs ThNM10,735.2-  
INCOME DATA
Net Sales Rs m6,844393,100 1.7%  
Other income Rs m215,500 0.4%   
Total revenues Rs m6,865398,600 1.7%   
Gross profit Rs m1,13188,800 1.3%  
Depreciation Rs m1285,650 2.3%   
Interest Rs m398330 120.6%   
Profit before tax Rs m62688,320 0.7%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m-50-2,280 2.2%   
Tax Rs m12125,440 0.5%   
Profit after tax Rs m45560,600 0.8%  
Gross profit margin %16.522.6 73.2%  
Effective tax rate %19.328.8 67.1%   
Net profit margin %6.615.4 43.1%  
BALANCE SHEET DATA
Current assets Rs m4,904119,140 4.1%   
Current liabilities Rs m3,58186,670 4.1%   
Net working cap to sales %19.38.3 234.0%  
Current ratio x1.41.4 99.6%  
Inventory Days Days12424 519.9%  
Debtors Days Days10017 594.0%  
Net fixed assets Rs m1,68951,210 3.3%   
Share capital Rs m2622,160 12.1%   
"Free" reserves Rs m2,35876,510 3.1%   
Net worth Rs m2,63578,670 3.3%   
Long term debt Rs m5070-   
Total assets Rs m6,862186,290 3.7%  
Interest coverage x2.6268.6 1.0%   
Debt to equity ratio x0.20-  
Sales to assets ratio x1.02.1 47.3%   
Return on assets %12.432.7 38.0%  
Return on equity %17.377.0 22.4%  
Return on capital %31.0109.8 28.2%  
Exports to sales %4.00-   
Imports to sales %00-   
Exports (fob) Rs m273NA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m2733,240 8.4%   
Fx outflow Rs m213,820 0.0%   
Net fx Rs m271-10,580 -2.6%   
CASH FLOW
From Operations Rs m-31358,000 -0.5%  
From Investments Rs m-489-4,380 11.2%  
From Financial Activity Rs m769-53,900 -1.4%  
Net Cashflow Rs m-33-280 11.6%  

Share Holding

Indian Promoters % 25.5 0.0 -  
Foreign collaborators % 0.0 67.3 -  
Indian inst/Mut Fund % 9.2 4.1 224.4%  
FIIs % 0.0 14.1 -  
ADR/GDR % 0.0 0.0 -  
Free float % 65.3 14.5 450.3%  
Shareholders   13,061 322,351 4.1%  
Pledged promoter(s) holding % 99.7 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare AMAR REMEDIES With:   RELAXO FOOTWEARS  BATA INDIA  P&G HYGIENE  MARICO  GODREJ INDUSTRIES  

Compare AMAR REMEDIES With:   UNILEVER PLC. (UK)  P&G (US)  HYPERMARCAS (Brazil)  



Today's Market

Sensex Trades Marginally Lower; Axis Bank & Infosys Top Losers(12:30 pm)

Share markets in India are presently trading on a cautious note, ahead of the release of domestic GDP data.

Related Views on News

HUL Announces Quarterly Results (4QFY20); Net Profit Down 1.2% (Quarterly Result Update)

May 4, 2020 | Updated on May 4, 2020

For the quarter ended March 2020, HUL has posted a net profit of Rs 15 bn (down 1.2% YoY). Sales on the other hand came in at Rs 90 bn (down 9.4% YoY). Read on for a complete analysis of HUL's quarterly results.

HUL Announces Quarterly Results (3QFY20); Net Profit Up 11.9% (Quarterly Result Update)

Feb 1, 2020 | Updated on Feb 1, 2020

For the quarter ended December 2019, HUL has posted a net profit of Rs 16 bn (up 11.9% YoY). Sales on the other hand came in at Rs 98 bn (up 2.6% YoY). Read on for a complete analysis of HUL's quarterly results.

HUL Announces Quarterly Results (2QFY20); Net Profit Up 21.2% (Quarterly Result Update)

Oct 15, 2019 | Updated on Oct 15, 2019

For the quarter ended September 2019, HUL has posted a net profit of Rs 18 bn (up 21.2% YoY). Sales on the other hand came in at Rs 99 bn (up 6.7% YoY). Read on for a complete analysis of HUL's quarterly results.

HUL Announces Quarterly Results (1QFY20); Net Profit Up 14.8% (Quarterly Result Update)

Jul 25, 2019 | Updated on Jul 25, 2019

For the quarter ended June 2019, HUL has posted a net profit of Rs 18 bn (up 14.8% YoY). Sales on the other hand came in at Rs 101 bn (up 6.6% YoY). Read on for a complete analysis of HUL's quarterly results.

HUL 2018-19 Annual Report Analysis (Annual Result Update)

Jun 7, 2019 | Updated on Jun 7, 2019

Here's an analysis of the annual report of HUL for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of HUL. Also includes updates on the valuation of HUL.

More Views on News

Most Popular

What the RBI's Rate Cut Means for Options Traders(Fast Profits Daily)

May 25, 2020

The RBI governor has cut the repo rate to 4%. What does this mean for options traders? Find out in this video.

6 Charts Showing the State of Indian Financial Markets in 2020(Sector Info)

May 26, 2020

Six charts showing how Indian financial markets have performed in 2020 so far...

This 'Essential Product' Smallcap is a Must Have for a 'Covid-19' Immune Portfolio(Profit Hunter)

May 19, 2020

This smallcap company needs no stimulus measures to do well in the long term.

Which Stocks Should You Buy, Sell, and Hold in the Market Today?(Profit Hunter)

May 21, 2020

The coronavirus led uncertainty refuses to go away from the markets. Here's what retail investors should do with their stocks...

More

Get Rich as the
Market Rebounds from Covid-19

Coronavirus Rebound
Get this special guide, authored by Equitymaster's top analysts, now.
We will never sell or rent your email id.
Please read our Terms

AMAR REMEDIES SHARE PRICE


Dec 11, 2013 (Close)

TRACK AMAR REMEDIES

  • Track your investment in AMAR REMEDIES with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

AMAR REMEDIES 5-YR ANALYSIS

COMPARE AMAR REMEDIES WITH

MARKET STATS